Cost comparison of finasteride and dutasteride for enlarged prostate in a managed care setting among Medicare-aged men.

Naslund, Michael; Eaddy, Michael T; Kruep, Eric J; Hogue, Susan L

Naslund, Michael; Eaddy, Michael T; Kruep, Eric J; Hogue, Susan L.

Affiliation

Naslund M; University of Marlyand School of Medicine, Baltimore, MD, USA. mnaslund@smail.umaryland.edu

Am J Manag Care ; 14(5 Suppl 2): S167-71, 2008 May.

Article in En | MEDLINE | ID: mdl-18611091

Subject(s)

Azasteroids/economics; Enzyme Inhibitors/economics; Finasteride/economics; Prostatic Hyperplasia/drug therapy; Aged; Aged, 80 and over; Azasteroids/therapeutic use; Drug Costs; Dutasteride; Enzyme Inhibitors/therapeutic use; Finasteride/therapeutic use; Humans; Male; Managed Care Programs; Medicare; Prevalence; Prostatic Hyperplasia/economics; Retrospective Studies; United States

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Hyperplasia / Azasteroids / Finasteride / Enzyme Inhibitors Type of study: Health_economic_evaluation / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Male Country/Region as subject: America do norte Language: En Journal: Am J Manag Care Journal subject: SERVICOS DE SAUDE Year: 2008 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links